Early-stage drug candidate diminishes deficits in Parkinson's Disease

Chemical compound reduces alpha-synuclein, cell stress.

Related Keywords

Stefan Pulst ,Mandi Gandelman ,Duong Huynh ,Daniel Scoles ,National Center ,University Of Utah Health ,Department Of Neurology ,National Institutes Of Health ,Translational Sciences ,Research Associate Professor ,Michaelj Fox Foundation For Parkinson Research ,Intramural Research Program ,Utah Health ,Associate Professor ,Neurology Daniel Scoles ,Advancing Translational Sciences ,Research Program ,National Institutes ,